🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

449 results for “Sun” Clear

  1. [14C]- Rongliflozin

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Adult Male Volunteers

    phase 1 small molecule completed

    1 trial

  2. [14C]-HEC585

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  3. [14C]-Larotinib

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Adult Male Volunteers

    phase 1 small molecule completed

    1 trial

  4. [14C]Clifutinib

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Adult Male

    phase 1 small molecule completed

    1 trial

  5. [14C]SSS17

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Subjects (HS)

    phase 1 small molecule active

    1 trial

  6. new formulations of 611

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Atopic Dermatitis

    phase 1 small molecule active

    1 trial

  7. pyroglutamate rongliflozin capsules

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Type 2 Diabetes

    phase 1 small molecule completed

    1 trial

  8. pyroglutamate rongliflozin capsules

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Diabetes Mellitus, Type 2

    phase 1 small molecule completed

    1 trial

  9. recombinant human thrombopoietin injection

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Liver Disease Chronic

    phase 1 small molecule active

    1 trial

  10. yimitasvir

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Hepatitis c

    phase 1 small molecule completed

    1 trial

  11. 0.1% bromfenac

    Zhongshan Ophthalmic Center, Sun Yat-sen University

    Pterygium

    approved small molecule completed

    1 trial

  12. Amodiaquine plus Artesunate co-administration

    United Therapeutics Europe Ltd

    Malaria

    approved small molecule completed

    1 trial

  13. Artesunate-amodiaquine combination

    United Therapeutics Europe Ltd

    Malaria,Falciparum

    approved small molecule completed

    1 trial

  14. CAPECITABINE, CALCIUM FOLINATE, KEYTRUDA 25 mg/mL concentrate for solution for infusion, Calciumfolinat Kabi 10 mg/ml Injektions-/Infusionslösung, FLUOROURACIL, Lenvatinib, Lenvatinib, Calciumfolinat-GRY® 100 mg/10 ml Injektionslösung, OXALIPLATIN, Lenvatinib, CALCIUM LEVOFOLINATE , CAPECITABINE

    Merck Sharp and Dohme

    Advanced/Metastatic Gastroesophageal Adenocarcinoma

    approved small molecule active

    1 trial

  15. Ceftolozane/tazobactam

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Bronchiectasis

    approved small molecule active

    1 trial

  16. EPIAO®

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Renal Anaemia

    approved small molecule terminated

    1 trial

  17. IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM., Rixathon 500 mg concentrate for solution for infusion, Bortezomib Hikma 3,5 mg Pulver zur Herstellung einer Injektionslösung, Rixathon 100 mg concentrate for solution for infusion, MTX HEXAL 2,5 mg Tabletten, -, Methotrexat-GRY® 50 mg/2 ml Injektionslösung, ASFOTASE ALFA

    Alexion Europe SAS

    HYPOPHOSPHATASIA

    approved small molecule active

    1 trial

  18. Peginterferon alfa

    Third Affiliated Hospital, Sun Yat-Sen University

    Chronic Hepatitis B

    approved small molecule active

    1 trial

  19. Rabipur Pulver und Lösungsmittel zur Herstellung einer Injektionslösung in einer Fertigspritze Tollwut-Impfstoff (inaktiviert), RABIPUR, poudre et solvant pour solution injectable en seringue préremplie. Vaccin rabique (inactivé)., Rabipur poeder en oplosmiddel voor oplossing voor injectie in een voorgevulde spuit.Rabiësvaccin (geïnactiveerd).

    The George Institute

    rabies pre-exposure prophylaxis

    approved small molecule active

    1 trial

  20. Rebamipide 2% ophthalmic solution

    Samsung Bioepis NL B.V.

    Dry Eye Disease (DED)

    approved small molecule active

    1 trial

  21. Sitagliptin

    Chen Suning

    Type 2 Diabetes

    approved small molecule completed

    1 trial

  22. Sulforaphane

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    HIV Infections

    approved small molecule active

    1 trial

  23. TPO

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    ITP

    approved small molecule completed

    1 trial

  24. doxazosin plus tolterodine SR

    Samsung Bioepis NL B.V.

    Overactive Bladder

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources